BMRN, AFFY, THRX, and RIGL are the most likely candidates for the next significant biotech buyout, according to Piper Jaffray: http://finance.yahoo.com/news/piper-discusses-potential-takeout-candidates-112833520.html Putting THRX on the list was made easier by today’s news in #msg-77146713.